These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 2566544

  • 1. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W.
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [Abstract] [Full Text] [Related]

  • 2. What are the differences between the H2-receptor antagonists?
    Schunack W.
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
    [Abstract] [Full Text] [Related]

  • 3. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD, Schubert ML.
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [Abstract] [Full Text] [Related]

  • 6. Clinical importance of the new H2-antagonists.
    Walt RP.
    Methods Find Exp Clin Pharmacol; 1989 Sep; 11 Suppl 1():97-9. PubMed ID: 2566730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD, Grant SM, Goa KL.
    Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histamine H2-receptor antagonists.
    Keithley JK.
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM, Clissold SP.
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ, Stables R.
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.